微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 47.13% | 1.83% | -0.89% | 82/141 | 52.4% | 佰仁医疗 | 88.71% | 行业排名> |
| 2026-03-31 | 47.55% | -1.66% | 1.63% | 80/141 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 46.79% | -2.49% | 0.6% | 80/141 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 46.51% | -4.13% | 0.49% | 82/141 | 52.23% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 46.28% | -4.12% | -4.29% | 83/141 | 52.48% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 48.35% | 1.76% | 0.77% | 78/141 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 47.99% | -1.27% | -1.09% | 83/141 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 48.51% | -1.02% | 0.5% | 80/141 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 48.27% | -3.28% | 1.59% | 81/141 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 47.52% | -6.86% | -2.23% | 78/141 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 48.6% | 0.93% | -0.83% | 82/141 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 49.01% | 3.82% | -1.81% | 76/141 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 49.91% | -1.9% | -2.16% | 74/141 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 51.02% | 0.97% | 5.94% | 76/141 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 48.15% | -3.97% | 2.01% | 82/141 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 47.21% | -6.83% | -7.22% | 78/141 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 50.88% | 0.55% | 0.69% | 78/141 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 50.53% | 0.62% | 0.77% | 74/141 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 50.15% | -0.69% | -1.03% | 84/141 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 50.67% | 0.16% | 0.13% | 74/141 | 59.77% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 50.6% | 0.16% | 0.76% | 80/141 | 59.05% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 50.22% | 0.1% | -0.55% | 72/141 | 61.5% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 50.49% | -5.85% | -0.19% | 86/141 | 60.12% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 50.59% | -5.01% | 0.13% | 66/141 | 62.21% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 50.52% | 2% | 0.71% | 81/141 | 60.36% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 50.17% | -3.43% | -6.46% | 49/141 | 58.8% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 53.63% | 5.68% | 0.7% | 66/141 | 56.96% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 53.26% | 2% | 2.52% | 34/141 | 55.83% | 正海生物 | 93.78% | 行业排名> |
| 2019-03-31 | 51.95% | 2% | 2.37% | 25/141 | 52.61% | 正海生物 | 93.09% | 行业排名> |
| 2018-12-31 | 50.75% | -4.02% | -4.02% | 62/141 | 56.22% | 正海生物 | 93.85% | 行业排名> |
| 2017-12-31 | 52.87% | -0.05% | -0.05% | 58/141 | 56.1% | 正海生物 | 93.08% | 行业排名> |
| 2016-12-31 | 52.9% | 2% | 2% | 48/141 | 57.35% | 正海生物 | 92.83% | 行业排名> |